| Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia DY Logunov, IV Dolzhikova, DV Shcheblyakov, AI Tukhvatulin, ... The Lancet 397 (10275), 671-681, 2021 | 2071 | 2021 |
| Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia DY Logunov, IV Dolzhikova, OV Zubkova, AI Tukhvatulin, ... The Lancet 396 (10255), 887-897, 2020 | 1269 | 2020 |
| Safety and immunogenicity of GamEvac-Combi, a heterologous VSV-and Ad5-vectored Ebola vaccine: an open phase I/II trial in healthy adults in Russia IV Dolzhikova, OV Zubkova, AI Tukhvatulin, AS Dzharullaeva, ... Human vaccines & immunotherapeutics 13 (3), 613-620, 2017 | 139 | 2017 |
| Neutralizing activity of sera from Sputnik V-vaccinated people against variants of concern (VOC: B. 1.1. 7, B. 1.351, P. 1, B. 1.617. 2, B. 1.617. 3) and Moscow endemic SARS … VA Gushchin, IV Dolzhikova, AM Shchetinin, AS Odintsova, AE Siniavin, ... Vaccines 9 (7), 779, 2021 | 132 | 2021 |
| Toll-like receptors (TLRs): the role in tumor progression DV Shchebliakov, DY Logunov, AI Tukhvatulin, MM Shmarov, ... Acta Naturae (англоязычная версия) 2 (3 (6)), 21-29, 2010 | 97 | 2010 |
| Gam-COVID-Vac Vaccine Trial Group Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised … DY Logunov, IV Dolzhikova, DV Shcheblyakov, AI Tukhvatulin, ... Lancet 397 (10275), 671-681, 2021 | 89 | 2021 |
| Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate AV Kostarnoy, PG Gancheva, B Lepenies, AI Tukhvatulin, ... Proceedings of the National Academy of Sciences 114 (13), E2758-E2765, 2017 | 82 | 2017 |
| An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in … AI Tukhvatulin, IV Dolzhikova, DV Shcheblyakov, OV Zubkova, ... The Lancet Regional Health–Europe 11, 2021 | 67 | 2021 |
| Camelid VHHs fused to human fc fragments provide long term protection against botulinum neurotoxin a in mice SA Godakova, AN Noskov, ID Vinogradova, GA Ugriumova, AI Solovyev, ... Toxins 11 (8), 464, 2019 | 61 | 2019 |
| Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-κB, resulting in enhanced innate immune reactions and resistance to Salmonella … AI Tukhvatulin, II Gitlin, DV Shcheblyakov, NM Artemicheva, LG Burdelya, ... Infection and immunity 81 (10), 3855-3864, 2013 | 59 | 2013 |
| Non-thermal Plasma Causes p53-Dependent Apoptosis in Human Colon Carcinoma Cells SAE A I Tuhvatulin , E V Sysolyatina, D V Scheblyakov, D Yu Logunov, M M ... Acta Naturae 4 (3), 82-87, 2012 | 59* | 2012 |
| Interactions between Sulfated Polysaccharides from Sea Brown Algae and Toll-Like Receptors on HEK293 Eukaryotic Cells In Vitro ID Makarenkova, DY Logunov, AI Tukhvatulin, IB Semenova, ... Bulletin of experimental biology and medicine 154, 241-244, 2012 | 56 | 2012 |
| Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer A Ghochikyan, A Pichugin, A Bagaev, A Davtyan, A Hovakimyan, ... Journal of Translational Medicine 12, 1-12, 2014 | 54 | 2014 |
| Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and cellular adaptive immune responses AI Tukhvatulin, AS Dzharullaeva, NM Tukhvatulina, DV Shcheblyakov, ... PLoS One 11 (5), e0155650, 2016 | 52 | 2016 |
| Development of adenoviral vector-based mucosal vaccine against influenza IL Tutykhina, DY Logunov, DN Shcherbinin, MM Shmarov, AI Tukhvatulin, ... Journal of Molecular Medicine 89, 331-341, 2011 | 47 | 2011 |
| Topical bacterial lipopolysaccharide application affects inflammatory response and promotes wound healing AV Kostarnoy, PG Gancheva, DY Logunov, LV Verkhovskaya, MA Bobrov, ... Journal of Interferon & Cytokine Research 33 (9), 514-522, 2013 | 46 | 2013 |
| Non-thermal argon plasma is bactericidal for the intracellular bacterial pathogen Chlamydia trachomatis SA Ermolaeva, EV Sysolyatina, NI Kolkova, P Bortsov, AI Tuhvatulin, ... Journal of medical microbiology 61 (6), 793-799, 2012 | 40 | 2012 |
| Virus-vectored Ebola vaccines IV Dolzhikova, EA Tokarskaya, AS Dzharullaeva, AI Tukhvatulin, ... Acta Naturae (англоязычная версия) 9 (3 (33)), 4-11, 2017 | 33 | 2017 |
| Sulfated polysaccharides of brown seaweeds are ligands of toll-like receptors ID Makarenkova, DY Logunov, AI Tukhvatulin, IB Semenova, ... Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 6, 75-80, 2012 | 33 | 2012 |
| Safety and efficacy of the Russian COVID-19 vaccine: more information needed–Authors’ reply DY Logunov, IV Dolzhikova, AI Tukhvatullin, DV Shcheblyakov The Lancet 396 (10256), e54-e55, 2020 | 30 | 2020 |
Boris Naroditsky在 gamaleya.org 的电子邮件经过验证
